Matches in Nanopublications for { ?s ?p "[To determine whether Cav-1 cooperates with c-Myc in development of premalignant lesions and prostate cancer in vivo, we generated transgenic mice with c-Myc overexpression driven by the ARR(2)PB promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP210046.RAA3w-9InmtKZDky8INb4Ne17LLTDmZmizgTauCWFa36k130_assertion description "[To determine whether Cav-1 cooperates with c-Myc in development of premalignant lesions and prostate cancer in vivo, we generated transgenic mice with c-Myc overexpression driven by the ARR(2)PB promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP210046.RAA3w-9InmtKZDky8INb4Ne17LLTDmZmizgTauCWFa36k130_provenance.
- NP763983.RAkrNGWqYWkkSLXWEgZ6Y5tDh8ISZ5B03W8r4NPM-sfHI130_assertion description "[To determine whether Cav-1 cooperates with c-Myc in development of premalignant lesions and prostate cancer in vivo, we generated transgenic mice with c-Myc overexpression driven by the ARR(2)PB promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763983.RAkrNGWqYWkkSLXWEgZ6Y5tDh8ISZ5B03W8r4NPM-sfHI130_provenance.
- assertion description "[To determine whether Cav-1 cooperates with c-Myc in development of premalignant lesions and prostate cancer in vivo, we generated transgenic mice with c-Myc overexpression driven by the ARR(2)PB promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To determine whether Cav-1 cooperates with c-Myc in development of premalignant lesions and prostate cancer in vivo, we generated transgenic mice with c-Myc overexpression driven by the ARR(2)PB promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To determine whether Cav-1 cooperates with c-Myc in development of premalignant lesions and prostate cancer in vivo, we generated transgenic mice with c-Myc overexpression driven by the ARR(2)PB promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP944300.RAl-s_3W2wf9-1UpLK9lMnKtdT7ts3wvB6s37QVz5EPAU130_assertion description "[To determine whether Cav-1 cooperates with c-Myc in development of premalignant lesions and prostate cancer in vivo, we generated transgenic mice with c-Myc overexpression driven by the ARR(2)PB promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP944300.RAl-s_3W2wf9-1UpLK9lMnKtdT7ts3wvB6s37QVz5EPAU130_provenance.
- NP283948.RAy-JFxG7ewUsaFVcIiv51L6HR7TBLES5TEVr3cpksMrk130_assertion description "[To determine whether Cav-1 cooperates with c-Myc in development of premalignant lesions and prostate cancer in vivo, we generated transgenic mice with c-Myc overexpression driven by the ARR(2)PB promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283948.RAy-JFxG7ewUsaFVcIiv51L6HR7TBLES5TEVr3cpksMrk130_provenance.